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Purpose of the study
Tailoring of antiretroviral therapy (ART) in HIV-2
remains unclear, therefore therapeutic experience in this
population is presented.
Methods
Retrospective analysis of HIV-2 infected patients (pts)
on ART followed at a single Portuguese center, between
1988 and 2010.
Summary of results
37 pts were included; 19 (51%) female and 28 (76%)
Caucasian. Mean ages were: 46 years [18-77] at HIV-2
diagnosis and 48 years [20-81] at the beginning of ART.
The majority (54%; 20) was probably infected in West
Africa through heterosexual intercourse (75%, 28). The
average T CD4+ nadir was 137 cells/mm3 [3-586] and
mean TCD4+ count prior to ART initiation was 205
cells/mm3. The main reason for starting ART was
immunological deterioration (87%; 32) followed by preg-
nancy (8%; 3). Ten pts (27%) had an AIDS defining ill-
ness prior to ART initiation and 4 (11%) developed it
while on ART. The mean value of the last TCD4+
count was 305/mm3. Overall the median number of
regimens received per patient (pt) was 3 [1-7]; 12 (32%)
pts took just one regimen. Mean length of ART was 61
months [1-228] and mean duration of the last pre-
scribed regimen was 23 months [0.25-125]. Viral load
("in house” assay) was always undetectable in 19 (51%)
pts. Switch of ART occurred in 21 (57%) pts with 1.4
reasons/pt. The main cause for switching was GI intol-
erance (57%; 12), followed by failure (38%; 8), toxicity
(29%; 6) and simplification (19%; 4).
The last prescribed regimens were as follows:
a) 73% (27): 2 NRTIs + 1 PI [NRTIs: TDF/FTC (9),
AZT/3TC (7), TDF/3TC (6), others (5); PIs: LPV/r (13);
SQV/r (8); IDV/r (3); others (3)];
b) 19% (7): 2NRTIs (FTC/TDF) + 1 PI (DRV/r) + 1
INSTIs (RAL);
c) 8% (3): dual/triple NRTIs.
Only one pt on RAL was ART naïve. After a median
follow-up of 11 months [4-24] on RAL based regimens,
3 pts had undetectable viral load (the remaining had it
from the beginning). Median length of previous ART
was 77 months with an average of 2.4 regimens/pt. The
median gain of T CD4+ with RAL regimen was +94
cells/mm3 [3-239]. Currently: 21 (57%) pts are kept on
follow up, 19 (90%) of whom on ART; 9 (24%)pts died
(4 with AIDS related deaths) and 7 (19%)were lost to
follow-up.
Conclusions
This population had a fairly good T CD4 cell recovery
while on therapy which is the best approach to assess
treatment response together with clinical improvement.
NRTIs/PI/INSTI containing regimens appears to be
effective, although longer term outcomes are needed.
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